In agreement with our data, SNHG20 expression markedly increased in tumor tissues and promoted the malignant progression in laryngeal squamous cell carcinoma (Li et al., 2019), epithelial ovarian cancer (Wang et al., 2019), and osteosarcoma (Zhang et al., 2018). The gene discussed is SNHG20; the disease is ovarian carcinoma.